Desjardins Global Asset Management Inc. Catalent, Inc. Transaction History
Desjardins Global Asset Management Inc.
- $922 Million
- Q4 2023
A detailed history of Desjardins Global Asset Management Inc. transactions in Catalent, Inc. stock. As of the latest transaction made, Desjardins Global Asset Management Inc. holds 599 shares of CTLT stock, worth $33,981. This represents 0.0% of its overall portfolio holdings.
Number of Shares
599
Previous 585
2.39%
Holding current value
$33,981
Previous $26,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CTLT
# of Institutions
485Shares Held
172MCall Options Held
865KPut Options Held
687K-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.16 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15.2MShares$862 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA12.9MShares$733 Million0.12% of portfolio
-
Nomura Holdings Inc Tokyo, M011.3MShares$639 Million1.65% of portfolio
-
Janus Henderson Group PLC London, X09.56MShares$542 Million0.3% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $10.2B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...